Stock ADIL ADIAL PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Adial Pharmaceuticals, Inc.

Equities

ADIL

US00688A2050

Real-time Estimate Cboe BZX
Other stock markets
 17:05:21 21/05/2024 BST 		5-day change 1st Jan Change
1.425 USD -4.97% Intraday chart for Adial Pharmaceuticals, Inc. -0.76% -23.17%
04-22 Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder MT
04-12 Top Premarket Decliners MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
AQ
Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder
MT
Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
AQ
Top Premarket Decliners
MT
Top Midday Gainers
MT
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
AQ
Adial Pharmaceuticals, Inc Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
CI
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
AQ
Adial Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Adial Pharmaceuticals, Inc. announced that it has received $0.2875 million in funding
CI
Adial Pharmaceuticals, Inc. announced that it expects to receive $0.2875 million in funding
CI
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
AQ
Top Premarket Decliners
MT
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
AQ
Investors Await Key Economic Data, Markets Remain Flat Ahead of Opening Bell
MT
US Futures Remain Flat as Investors Await Raft of Economic Data
MT
Top Midday Gainers
MT
Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
AQ
Adial Pharmaceuticals Secures US Patent Allowance for AD04, Genetic Diagnostic Combination
MT
Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ADIL Stock
  4. News Adial Pharmaceuticals, Inc.